Collection
Digital Features - Dermatology
- Submission status
- Open
- Open for submission from
- 21 April 2021
- Submission deadline
- Ongoing
A collection of recent articles with digital features such as video abstracts published in the American Journal of Clinical Dermatology, Dermatology & Therapy and Advances in Therapy
Articles (81 in this collection)
-
-
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor)
Authors (first, second and last of 9)
- Melinda Gooderham
- Ronald Vender
- Lawrence Green
- Content type: Original Research
- Open Access
- Published: 09 February 2024
- Dermatology and Therapy
- Pages: 441 - 451
-
Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis
Authors (first, second and last of 9)
- Hidehisa Saeki
- Yoko Kataoka
- Kazuhiko Arima
- Content type: Brief Report
- Open Access
- Published: 07 February 2024
- Dermatology and Therapy
- Pages: 533 - 543
-
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Authors (first, second and last of 15)
- Brett King
- Jennifer Soung
- Alexandre Lejeune
- Content type: Original Research Article
- Open Access
- Published: 23 January 2024
- American Journal of Clinical Dermatology
- Pages: 299 - 314
-
OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target
Authors (first, second and last of 9)
- Michael Croft
- Ehsanollah Esfandiari
- Emma Guttman-Yassky
- Content type: Review Article
- Open Access
- Published: 18 January 2024
- American Journal of Clinical Dermatology
-
Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
Authors (first, second and last of 11)
- Amy S. Paller
- Andreas Pinter
- Mike Bastian
- Content type: Original Research
- Open Access
- Published: 09 January 2024
- Advances in Therapy
- Pages: 1046 - 1061
-
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Authors (first, second and last of 6)
- Eric L. Simpson
- Ben Lockshin
- Andrew Korotzer
- Content type: Brief Report
- Open Access
- Published: 04 January 2024
- Dermatology and Therapy
- Pages: 261 - 270
-
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1
Authors (first, second and last of 8)
- Eric L. Simpson
- Andrew Blauvelt
- Andreas Wollenberg
- Content type: Original Research Article
- Open Access
- Published: 07 October 2023
- American Journal of Clinical Dermatology
- Pages: 139 - 148
-
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis
Authors (first, second and last of 11)
- Michael J. Cork
- Diamant Thaçi
- Noah A. Levit
- Content type: Original Research
- Open Access
- Published: 26 September 2023
- Dermatology and Therapy
- Pages: 2697 - 2719
-
Burden of Herpes Zoster Among Patients with Psoriasis in the United States
Authors (first, second and last of 11)
- David Singer
- Philippe Thompson-Leduc
- Sara Poston
- Content type: Original Research
- Open Access
- Published: 22 September 2023
- Dermatology and Therapy
- Pages: 2649 - 2668
-
Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
Authors (first, second and last of 11)
- Diamant Thaçi
- Christos Tziotzios
- Ernest Law
- Content type: Original Research
- Open Access
- Published: 14 September 2023
- Dermatology and Therapy
- Pages: 2621 - 2634
-
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Authors (first, second and last of 4)
- Jonathan I. Silverberg
- April Armstrong
- Kristian Reich
- Content type: Review Article
- Open Access
- Published: 11 September 2023
- American Journal of Clinical Dermatology
- Pages: 913 - 925
-
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials
Authors (first, second and last of 14)
- Eric L. Simpson
- Andrew E. Pink
- Andreas Wollenberg
- Content type: Original Research Article
- Open Access
- Published: 08 September 2023
- American Journal of Clinical Dermatology
- Pages: 939 - 952
-
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
Authors (first, second and last of 7)
- April W. Armstrong
- Sang Hee Park
- Viktor Chirikov
- Content type: Original Research
- Open Access
- Published: 31 July 2023
- Dermatology and Therapy
- Pages: 2589 - 2603
-
Early Discontinuation of Apremilast in Patients with Psoriasis and Gastrointestinal Comorbidities: Rates and Associated Risk Factors
Authors (first, second and last of 7)
- Lana Schmidt
- Ching An Wang
- Lauren Seigel
- Content type: Original Research
- Open Access
- Published: 30 July 2023
- Dermatology and Therapy
- Pages: 2019 - 2030
-
Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice
Authors (first, second and last of 6)
- Melinda J. Gooderham
- Andrew E. Pink
- Melissa Watkins
- Content type: Review
- Open Access
- Published: 23 July 2023
- Dermatology and Therapy
- Pages: 1893 - 1907
-
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years
Authors (first, second and last of 10)
- Elaine C. Siegfried
- Eric L. Simpson
- Ainara RodrÃguez Marco
- Content type: Original Research
- Open Access
- Published: 22 July 2023
- Dermatology and Therapy
- Pages: 1987 - 2000
-
Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet’s Syndrome
Authors (first, second and last of 10)
- Philip J. Mease
- Gülen Hatemi
- Linda Stein Gold
- Content type: Original Research Article
- Open Access
- Published: 14 June 2023
- American Journal of Clinical Dermatology
- Pages: 809 - 820
-
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial
Authors (first, second and last of 9)
- Elaine C. Siegfried
- Michael J. Cork
- Annie Zhang
- Content type: Original Research Article
- Open Access
- Published: 10 June 2023
- American Journal of Clinical Dermatology
- Pages: 787 - 798
-
Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
Authors (first, second and last of 8)
- Prethibha George
- Oladayo Jagun
- Samuel H. Zwillich
- Content type: Original Research
- Open Access
- Published: 10 June 2023
- Dermatology and Therapy
- Pages: 1733 - 1746
-
Suboptimal Clinical and Quality of Life Outcomes in Patients with Psoriasis Undertreated with Oral Therapies: International Physician and Patient Survey
Authors (first, second and last of 7)
- Sydney Thai
- Sophie Barlow
- Jashin J. Wu
- Content type: Original Research
- Open Access
- Published: 31 May 2023
- Dermatology and Therapy
- Pages: 1289 - 1303
-
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
Authors (first, second and last of 14)
- Linda Stein Gold
- Diamant Thaçi
- Marjolein de Bruin-Weller
- Content type: Original Research Article
- Open Access
- Published: 17 May 2023
- American Journal of Clinical Dermatology
- Pages: 595 - 607
-
Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT Survey
Authors (first, second and last of 8)
- Joseph F. Merola
- Alexis Ogdie
- Mark Lebwohl
- Content type: Original Research
- Open Access
- Published: 15 May 2023
- Dermatology and Therapy
- Pages: 1329 - 1346
-
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study
Authors (first, second and last of 11)
- Lawrence F. Eichenfield
- Richard G. Gower
- John Werth
- Content type: Original Research Article
- Open Access
- Published: 15 May 2023
- American Journal of Clinical Dermatology
- Pages: 623 - 635
-
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy
Authors (first, second and last of 14)
- Eftychia Chatziioannou
- Ulrike Leiter
- Teresa Amaral
- Content type: Original Research Article
- Open Access
- Published: 04 May 2023
- American Journal of Clinical Dermatology
- Pages: 453 - 467
-
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
Authors (first, second and last of 11)
- Ohsang Kwon
- Maryanne M. Senna
- Brett King
- Content type: Original Research Article
- Open Access
- Published: 01 March 2023
- American Journal of Clinical Dermatology
- Pages: 443 - 451
-
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials
Authors (first, second and last of 12)
- Jonathan I. Silverberg
- Charles W. Lynde
- Noah A. Levit
- Content type: Original Research Article
- Open Access
- Published: 20 February 2023
- American Journal of Clinical Dermatology
- Pages: 469 - 483
-
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study
Authors (first, second and last of 12)
- Akihiko Asahina
- Yukari Okubo
- Hidemi Nakagawa
- Content type: Original Research
- Open Access
- Published: 17 January 2023
- Dermatology and Therapy
- Pages: 751 - 768
-
Novel Therapies in Plaque Psoriasis: A Review of Tyrosine Kinase 2 Inhibitors
Authors
- George Martin
- Content type: Review
- Open Access
- Published: 02 January 2023
- Dermatology and Therapy
- Pages: 417 - 435
-
Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data
Authors (first, second and last of 12)
- Amit Garg
- Haley B. Naik
- Alexa B. Kimball
- Content type: Original Research
- Open Access
- Published: 31 December 2022
- Dermatology and Therapy
- Pages: 581 - 594
-
Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial
Authors (first, second and last of 12)
- Sonja Ständer
- Shawn G. Kwatra
- Claire Feeney
- Content type: Original Research Article
- Open Access
- Published: 13 December 2022
- American Journal of Clinical Dermatology
- Pages: 97 - 107
-
Economic Burden of Comorbidities in Patients with Psoriasis in the USA
Authors (first, second and last of 6)
- Jashin J. Wu
- Manasi Suryavanshi
- Lauren Seigel
- Content type: Original Research
- Open Access
- Published: 19 November 2022
- Dermatology and Therapy
- Pages: 207 - 219
-
No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab
Authors (first, second and last of 10)
- Andrew Blauvelt
- Andreas Wollenberg
- Sonya L. Cyr
- Content type: Brief Report
- Open Access
- Published: 01 November 2022
- Advances in Therapy
- Pages: 367 - 380
-
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials
Authors (first, second and last of 7)
- Jonathan I. Silverberg
- Mark Boguniewicz
- Noah A. Levit
- Content type: Original Research
- Open Access
- Published: 21 October 2022
- Dermatology and Therapy
- Pages: 2731 - 2746
-
Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
Authors (first, second and last of 13)
- Amy S. Paller
- Gil Yosipovitch
- Dimittri Delevry
- Content type: Brief Report
- Open Access
- Published: 21 October 2022
- Dermatology and Therapy
- Pages: 2839 - 2850
-
Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis
Authors (first, second and last of 5)
- April Armstrong
- Qian Xia
- Lauren Seigel
- Content type: Original Research
- Open Access
- Published: 10 August 2022
- Dermatology and Therapy
- Pages: 2087 - 2103
-
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis
Authors (first, second and last of 12)
- Jonathan I. Silverberg
- David N. Adam
- Stephan Weidinger
- Content type: Original Research Article
- Open Access
- Published: 20 July 2022
- American Journal of Clinical Dermatology
- Pages: 547 - 559
-
Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults
Authors (first, second and last of 8)
- Lida Teng
- Akiko Mizukami
- Taizo Matsuki
- Content type: Original Research
- Open Access
- Published: 06 June 2022
- Dermatology and Therapy
- Pages: 1447 - 1467
-
Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis
Authors (first, second and last of 6)
- El-Bdaoui Haddad
- Sonya L. Cyr
- Frank O. Nestle
- Content type: Review
- Open Access
- Published: 21 May 2022
- Dermatology and Therapy
- Pages: 1501 - 1533
-
Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE)
Authors (first, second and last of 14)
- Jerry Bagel
- Tien Q. Nguyen
- Marius Ardeleanu
- Content type: Original Research
- Open Access
- Published: 20 May 2022
- Dermatology and Therapy
- Pages: 1417 - 1430
-
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)
Authors (first, second and last of 16)
- Andrew Blauvelt
- Emma Guttman-Yassky
- Ashish Bansal
- Content type: Original Research Article
- Open Access
- Published: 14 May 2022
- American Journal of Clinical Dermatology
- Pages: 365 - 383
-
Real-World Treatment Patterns and Outcomes Among Patients with Basal Cell Carcinoma Following First-Line Hedgehog Inhibitor Discontinuation
Authors (first, second and last of 9)
- Lance Cowey
- Chieh-I. Chen
- Jessica J. Jalbert
- Content type: Original Research
- Open Access
- Published: 04 May 2022
- Dermatology and Therapy
- Pages: 1211 - 1224
-
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis
Authors (first, second and last of 14)
- Lisa A. Beck
- Mette Deleuran
- Arsalan Shabbir
- Content type: Original Research Article
- Open Access
- Published: 03 May 2022
- American Journal of Clinical Dermatology
- Pages: 393 - 408
-
Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials
Authors (first, second and last of 8)
- Sanjay Chabra
- B. J. Gill
- Luis Puig
- Content type: Original Research
- Open Access
- Published: 21 April 2022
- Advances in Therapy
- Pages: 2862 - 2872
-
Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis
Authors (first, second and last of 8)
- Craig L. Leonardi
- Kyoungah See
- Richard B. Warren
- Content type: Original Research
- Open Access
- Published: 22 March 2022
- Advances in Therapy
- Pages: 2256 - 2269
-
Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study
Authors (first, second and last of 10)
- Andrew Alexis
- Marjolein de Bruin-Weller
- Natalie Yin
- Content type: Original Research
- Open Access
- Published: 17 March 2022
- Dermatology and Therapy
- Pages: 771 - 785
-
Pathophysiology of Generalized Pustular Psoriasis
Authors
- Slaheddine Marrakchi
- Lluis Puig
- Content type: Review Article
- Open Access
- Published: 21 January 2022
- American Journal of Clinical Dermatology
- Pages: 13 - 19
-
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey
Authors (first, second and last of 6)
- Dale V. Reisner
- Frida Dunger Johnsson
- Kilian Eyerich
- Content type: Original Research Article
- Open Access
- Published: 21 January 2022
- American Journal of Clinical Dermatology
- Pages: 65 - 71
-
The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis
Authors
- Min Zheng
- Denis Jullien
- Kilian Eyerich
- Content type: Review Article
- Open Access
- Published: 21 January 2022
- American Journal of Clinical Dermatology
- Pages: 5 - 12
-
Clinical Disease Measures in Generalized Pustular Psoriasis
Authors (first, second and last of 5)
- A. David Burden
- Siew Eng Choon
- Richard B. Warren
- Content type: Review Article
- Open Access
- Published: 21 January 2022
- American Journal of Clinical Dermatology
- Pages: 39 - 50